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A novel cyclin, CCNY, was identiﬁed as a PFTK1 interacting protein in a yeast two-hybrid screen. The
cyclin box in CCNY and the PFTAIRE motif in PFTK1 are both required for the interaction which was
conﬁrmed by in vivo and in vitro assays. Two transcripts (4 and 2 kb), of CCNY were detected by
Northern blot analysis and CCNY was enriched at the plasmamembrane due to an N-terminal myris-
toylation signal. We propose that binding of CCNY to PFTK1 enhances PFTK1 kinase activity and
changes its intracellular location.
Structured summary:
MINT-7147585, MINT-7147598, MINT-7147614, MINT-7147628, MINT-7147647, MINT-7147665, MINT-
7147680: pftk1 (uniprotkb:O94921) physically interacts (MI:0915) with CCNY (uniprotkb:Q8ND76) by two
hybrid (MI:0018)
MINT-7147725, MINT-7147743: pftk1 (uniprotkb:O94921) physically interacts (MI:0914) with CCNY (uni-
protkb:Q8ND76) by anti tag coimmunoprecipitation (MI:0007)
MINT-7147758: pftk1 (uniprotkb:O35495) physically interacts (MI:0914) with CCNY (uniprotkb:Q8BGU5)
by anti bait coimmunoprecipitation (MI:0006)
MINT-7147695, MINT-7147713: pftk1 (uniprotkb:O94921) and CCNY (uniprotkb:Q8ND76) colocalize
(MI:0403) by ﬂuorescence microscopy (MI:0416)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The cyclins are a family of proteins, which are identiﬁed by a
homologous region of about 100 amino acid residues, termed cy-
clin box which directs cyclin–CDK interaction [1]. Cyclins are reg-
ulatory subunits that associate with speciﬁc CDKs through the
cyclin box to form functional protein kinase complexes. The CDKs
are a family of Ser/Thr protein kinases that share a highly con-
served PSTAIRE motif which is involved in cyclin binding and has
been used to classify CDK-related kinases [2,3]. The activity of
CDK is tightly regulated in part by its subcellular localization [4].
The speciﬁc subcellular compartment where CDKs are located to,
may deﬁne a speciﬁc substrate to be phosporylated, and thus a
speciﬁc function to be induced. Cyclins play a role in regulating
the localization of CDKs. For instance, cyclin B1 can target CDK1
to the intracellular membranes, cytoplasm or nucleus during the
cell cycle, whereas cyclin B2 retained CDK1 on intracellular mem-
brane [5–7]. Different localization of the B-type cyclin–CDKs en-
ables cyclin B1–CDK1 to cause chromosome condensation,
microtubule reorganization, and disassembly of the nuclear laminachemical Societies. Published by Eand of the Golgi apparatus, while restricts cyclin B2–CDK1 to dis-
assembly of the Golgi apparatus [7].
PFTK1has recentlybeencharacterizedasaCDKthat regulates cell
cycleprogressionand cell proliferation. It can interactwith cyclinD3
(CCND3), forming a ternary complex with the cell cycle inhibitor
p21Cip1 inmammaliancells. Its kinase activity is enhancedbyCCND3
and inhibited by p21Cip1 [3]. PFTK1 belongs to the subgroup of Cdc2-
related kinase family, which includes mammalian PFTAIRE,
PCTAIRE, PITSLRE, PISSLRE, etc. [3,8–14]. These kinases derive their
names from the characteristic amino acid sequence in the cyclin
binding motif PSTAIRE and display a peculiar pattern of expression
with high levels in post-mitotic tissue [13]. This suggests that their
function is not restricted to the regulation of proliferation, and also
is involved in control of post-mitotic cellular process [10,13]. Rela-
tively little is known, however, about the function of most of these
kinases, as their cyclinpartners remainunidentiﬁed.CDK5was iden-
tiﬁed as PSSALRE and is also onemember of the Cdc2-related kinase
subfamily. Great advances have been made in understanding the
function of CDK5 since the two activation regulators, p35 and p39,
have been identiﬁed. Although p35 and p39 share little sequence
identitywith other cyclins in their amino acid sequences, they share
similarity to cyclins in the ternary structure [15–19]. Like the CDK
regulatory subunits (cyclins), p35 or p39, is required for the kinaselsevier B.V. All rights reserved.
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The subcellular distribution of CDK5 is also determined by p35 and
p39 [17]. p35andp39are targeted to the cellmembranebyN-myris-
toylation [16,20]. CDK5 alone does not show a speciﬁc distribution
pattern, but is recruited to the cell membranewhen associatedwith
p35 or p39 [21]. Therefore, the transmembrane or membrane-asso-
ciatedproteins are likely to be physiological substrates of CDK5 [21].
AlthoughCDKsare traditionally involved in regulatingcell cyclepro-
gression, CDK5 functions in various events throughout the life span
of neurons, from development to cell death. For instance, it plays
critical roles in neuronal apoptosis, neuronal migration and axon
guidance, synaptic neurotransmission,membrane transport, aswell
as regulation of the cytoskeleton [17,21,22].
We previously reported the isolation of human PFTAIRE1
(PFTK1) which is highly expressed in brain, pancreas, kidney, heart,
testis and ovary [8]. To search its substrate and regulatory proteins,
we screened a two-hybrid library and identiﬁed seven PFTK1 inter-
acting factors including four 14-3-3 isoforms (b, e, g, s) [23], a sep-
tin family member KIAA0202 (SEPT8) [24], PLZF protein [25] and a
novel cyclin-like protein, named cyclin Y (CCNY), which we study
in this paper.2. Materials and methods
2.1. Plasmid construction
A 2.1 kb insert containing full length ORF of CCNY obtained
from the yeast two-hybrid screening and a cDNA containing full
length ORF of PFTK1 were used for further subcloning. The CCNY
cDNA and its deletion fragments were ampliﬁed by PCR and sub-
cloned into pGilda or pB42AD for BD fusion or AD fusion construc-
tion. PFTK1 mutants (K164R, H224N, D256A, F176D, S119A/S282A)
were generated by PCR ampliﬁcation using Mutagenesis kit
(Strategene). PFTK1 and its mutants were subcloned into pGilda
or pB42AD for BD fusion or AD fusion construction for yeast two-
hybrid assay. Wild type and point mutation variants including
G2A and N3A of CCNY were ampliﬁed by PCR and subcloned into
different expression vectors including pEGFP-N3 (Clontech), pEG-
FP-C2, pcDNA3-2HA and pMycN3 [26] for ectopic expression. The
PFTK1 and PFTK1 F176D mutant fragments were inserted into
pEGFP-C2 for expression in 293T cells.
2.2. Yeast two-hybrid assay
The yeast two-hybrid screen and yeast two-hybrid interaction
assay were carried out as described [23].
2.3. Northern blot analysis
Human multiple tissue Northern blots (Clontech) were used
for analyzing the expression pattern of CCNY in human tissues.
Total RNA was made from different cell lines, loaded and ana-
lyzed by the probes in parallel. A 1026 bp cDNA fragment con-
taining whole coding region of the CCNY (CCNY probe) and a
162 bp cDNA corresponding to nucleotide 1–162 of the CCNY
ORF (CCNY-N probe) were used as probes for Northern hybridiza-
tion analysis. Human b-actin cDNA was used as loading control.
Northern blot analysis was performed according to standard lab-
oratory manual.
2.4. Cell fractionation and Western blot analysis
Cell fractionation was performed using the Mem-PER Eukary-
otic Membrane Protein Extraction Kit (Pierce) and the NE-PER Nu-
clear and Cytoplasmic Fractionation Kit (Pierce) according to themanufacturer’s instructions. The purity of these fractions was
determined using a mouse monoclonal antibody to GAPDH as a
cytoplasmic marker (1/5000, Kangchen), rabbit polyclonal to His-
tone H3 (1/5000; Abcam) as a nuclear marker and goat mAb to
TFR (1/300; Santa Cruz) as a membrane marker. Western blot anal-
ysis was performed according to standard laboratory manual.
2.5. Co-immunoprecipitation and kinase assays
Transfected 293T cells were lysed with lysis buffer (50 mM Tris
[pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% NP-40 and 0.5% sodium
deoxycholate) and complete EDTA-free protease inhibitor cocktail
(Roche). Immunoprecipitations were performed using protein G
(Roche) according to the manufacturer’s instructions. For kinase
assays, the activity of PFTK1 was determined as described [27]
with some modiﬁcations. Brieﬂy, the immunoprecipitates were
washed three times with the same lysis buffer and once with the
wash buffer (50 mM HEPES pH 7.5, 1 mM DTT). The 25 ll reaction
mixture, containing 50 mM HEPES pH 7.5, 1 mM DTT, 10 mM
MgCl2, 20 lM ATP, 10 lCi c-[32P]ATP and 0.4 lg retinoblastoma
protein (RbC137) (Abcam), was added to the immunoprecipitate,
and the enzyme reaction was continued for 30 min at 30 C. Reac-
tions were stopped by the addition of SDS–PAGE loading buffer,
and the samples were separated on SDS–PAGE and visualized by
autoradiography.
2.6. Immunoﬂuorescence microscopy
Transfected 293T cells were ﬁxed with 4% paraformaldehyde for
20 min at room temperature, washed with phosphate-buffed sal-
ine (PBS) and permeabilized with 0.1% Triton X-100 in blocking
solution (5% BSA in PBS) for 1 h. For immunostaining, the cells
were incubated with either anti-Myc (Santa Cruz, 1:150 dilution),
or anti-HA (Cell Signaling Technology, 1:150 dilution) in blocking
solution for 3 h followed by incubation with secondary antibodies
coupled to FITC or TRITC (Sigma, 1:400 dilution) for 1 h. To visual-
ize nuclei, cells were incubated in 1 lg/ml 4,6-diamidino-2-phen-
ylindole (DAPI) in PBS. Coverslips were mounted and observed
under Zeiss confocal microscope.3. Results and discussion
3.1. Identiﬁcation of CCNY as a PFTK1 interacting protein by yeast two-
hybrid screening
Human PFTK1 was ﬁrst reported as a Cdc2-related kinase highly
expressed in human brain [8] and identiﬁed as a CDK involved in
cell cycle regulation [3]. When we used PFTK1 as a bait to screen
a human brain LexA two-hybrid library [23], a novel cyclin, named
cyclin Y (CCNY) was isolated. The assignment of CCNY as a cyclin is
primarily based on its structural similarity to other known cyclins.
Interactions between the full length PFTK1 and CCNY were con-
ﬁrmed by direct yeast two-hybrid analysis (Fig. 1A).
From analysis of the primary sequence, CCNY contains a cyclin
boxwhich is an essential characteristic of cyclin family in its central
region. Comparison of the cyclin box sequences in CCNY, cyclin A
(CCNA) and cyclin D (CCND) showed a high similarity between
these proteins (Fig. 1B). To determine whether the cyclin box is cru-
cial for interaction with PFTK1, seven CCNY deletion mutants were
constructed for the yeast two-hybrid assay. As shown in Fig. 1C, the
CCNY D(154–195) mutant abolished the b-galactosidase activity,
indicating that the central cyclin box in CCNY is crucial for the inter-
action with PFTK1. Besides the CCNY D(154–195) mutant, the
interaction was also lost in the CCNY (137–341) and CCNY (1–
243) mutants. The CCNY (84–341) mutant also showed a lower
Fig. 1. Interaction between CCNY and PFTK1 in a yeast two-hybrid system. (A) Identiﬁcation of CCNY as a PFTK1 interacting protein. (B) Alignment of cyclin box sequences in
human CCNY, cyclin A and cyclin D. Sequence alignments were performed using ClustalX program. Members of a similar residue group are indicated in same color. (C)
Mapping the binding regions on CCNY for PFTK1. (left) Schematic representation of CCNY deletion. (right) Two-hybrid assay. (D) Mapping the CCNY binding sites on PFTK1.
(left) Schematic representation of PFTK1 mutants. (right) Two-hybrid assay. The motifs and domains are predicted by ScanProsite (http://www.expasy.ch/tools/scanprosite/).
The results are representative of 2–4 independent experiments.
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conclude that both the cyclin box domain and regions ﬂanking
the cyclin box are required for the interaction with PFTK1 (Fig. 1C).
PFTK1 contains many predicted domains and motifs conserved
in protein kinases, including ATP binding region, Ser/Thr kinase
signature, etc. [23]. To further map the CCNY-interacting region
of PFTK1, we constructed a series of PFTK1 mutants on these pre-
dicted domains and motifs. Besides the PFTK1 F176D mutant, all
the mutants showed b-galactosidase activity (Fig. 1D). The K164R
substitution occasionally showed no b-galactosidase activity in re-
peated experiments, suggesting that the putative ATP binding site
K164 may contribute to the binding of CCNY. The PSTAIRE motif in
many CDKs is the primary site of intermolecular recognition in cy-clin binding [2]. The motif is also a speciﬁc binding site in CCNY
binding since the deletion of the phenylalanine in the PFTAIRE mo-
tif (PFTK1 F176D) prevents the binding of CCNY but has no effect
on the binding of 14-3-3 proteins (Fig. 1D). Taken together, our
data demonstrate an interaction between PFTK1 and CCNY. Both
the cyclin box in CCNY and the PFTAIRE motif in PFTK1 are re-
quired for the interaction, consisting with the features for speciﬁc
binding between cyclins and CDKs.
3.2. Two transcripts of CCNY are expressed in tissues and cell lines
CCNY is a 341 amino acid protein. The cDNA sequence encoding
for CCNY was submitted to GenBank with the accession number
2174 M. Jiang et al. / FEBS Letters 583 (2009) 2171–2178AY504868 (this sequence was replaced by GI: 71658801, Q8ND76).
By BLAST searching the up-to-date human genome database
(NCBI), the CCNY gene has been mapped to human chromosome
10p11.21, ﬂanked by CREM gene and GJD4 gene.
To determine tissue distribution of the CCNY transcripts, North-
ern blot hybridization was performed on poly(A) RNA isolated from
16 types of adult human tissues, with a CCNY probe. Two tran-
scripts of 4 and 2 kb were detected (Fig. 2A). The 4 kb transcript
was relatively ubiquitously expressed, being detected at low levels
in all the tissues examined. The 2 kb transcript was more restricted
in its expression, being detected at very high level in testis, med-
ium levels in heart and skeletal muscle, and low levels in the other
tissues, except in lung and thymus where the 2 kb transcript was
hardly detected. A weak hybridization band about 4.5 kb was de-
tected in testis, ovary and brain which may reﬂect more alterna-
tively spliced CCNY transcripts existing in these tissues.
To examine the transcriptional levels of CCNY in cell lines, we
extracted total RNA from 10 types of cell lines for Northern blot
analysis, using the CCNY probe for hybridization. As expected,
two transcripts of 4 and 2 kb were observed (Fig. 2B). The 4 kb
transcript was detected at low levels in all cell lines examined, ex-
cept in HepG2, where its expression level is higher than the others.
The 2 kb transcript was expressed at low level in the cell lines, but
abundant in HepG2. Besides the 4 and 2 kb transcripts, we also ob-
served a weak hybridization band about 3.8 kb in A431, HepG2,
B16 and NIH3T3, suggesting that the CCNY may have different
spliced forms in these cell lines.
From the database, two of CCNY isoforms representing alterna-
tively spliced CCNY transcripts are released. The one we isolated
encodes a 341 aa protein, another one encoding for a protein of
287 residues which was reported by Li et al. named as cyclin X
[28]. The two proteins differ in their N-terminal sequences. TheFig. 2. Expression pattern of CCNY mRNA in human tissues and cell lines. (A) Northern
hybridized with the CCNY probe (upper). The membranes were stripped and reprobed w
liver; SM: skeleton muscle; Ki: kidney; Pa: pancreas; Sp: spleen; Th: thymus; Pr: prostate
The image for CCNY was obtained after 7 days exposure and for b-actin was 24 h expos
were hybridized with the CCNY probe or the CCNY-N probe. The b-actin probe was useCCNY has a 54 amino acid extension at its N-terminus and is iden-
tical to the cyclin X through the rest of coding region. To determine
whether cyclin Y (CCNY) and cyclin X representing the 4 and 2 kb
transcripts, respectively, we performed Northern blot analysis by
using CCNY-N probe, which is speciﬁc for CCNY (Fig. 2C). Surpris-
ingly, both the 4 and 2 kb transcripts could be hybridized with
the CCNY-N probe, and showed a similar hybridization pattern gi-
ven by the CCNY probe. Combining our data and the information
from database suggests that the CCNY could be mainly transcribed
into two different transcripts, the cyclin X should be a shorter splic-
ing form of CCNY and other alternatively spliced CCNY transcripts
could also exist in different tissues or cell lines.
3.3. Ectopic expressed CCNY enriches at plasma membrane
To examine the cellular distribution of CCNY, CCNY was fused
with a C-terminal GFP tag (CCNY-GFP), expressed in 293T cells
and observed under a ﬂuorescence microscope. The results showed
that CCNY-GFP was localized to the plasma membrane (Fig. 3B). A
similar distribution was observed in ECV304, NIH3T3 and SHSY-5Y
cells (data not show). Fig. 3A shows an N-terminal myristoylation
signal motif exists in CCNY which is highly conserved in Mus mus-
culus, Rattus norvegicus, Xenopus laevis, Danio rerio, Drosophila
pseudoobscura and Caenorhabditis elegans CCNY orthologues. To
determine whether this myristoylation signal is essential for tar-
geting CCNY to the membrane, the conserved glycine at position
2 was mutated to alanine. The G2A mutant protein showed a dif-
fuse cytoplasmic distribution, with stronger nuclear accumulation
(Fig. 3B) contrasting to wild type CCNY which is associated with
the plasma membrane. As a control, the N3A mutant in which
the third asparagine residue was substituted with alanine was re-
tained at the plasma membrane just like the wild type CCNY. Inblot analysis of poly(A) + RNAs from various human tissues. Northern blots were
ith a human b-actin probe (lower). He: heart; Br: brain; Pl: placenta; Lu: lung; Li:
; Te: testis; Ov: ovary; SI: small intestine; Co: colon; PBL: peripheral blood leukocyte.
ure. (B) Northern blot analysis of total RNAs from various cell lines. Northern blots
d as a loading control.
Fig. 3. Cellular localization of CCNY and CCNY mutants. (A) N-terminal sequences
of wild-type CCNY, G2A mutant and N3A mutant. CCNY G2A represents a
substitution of second glycine residue with alanine, Gly? Ala. CCNY N3A repre-
sents a substitution of third asparagine residue with alanine, Asn? Ala. (B) The
second Gly is required for membrane localization of CCNY. The pEGFPN3-CCNY
(CCNY-GFP), pEGFPN3-CCNY-G2A (G2A-GFP), pEGFPN3-CCNY-N3A (N3A-GFP) and
pEGFPC2-CCNY (GFP-CCNY) constructs were separately transfected into 293T cells
for observation of the cellular localization. (C) Subcellular distribution of CCNY and
G2A in fractionated 293T cell lysates after transfection. Total protein (T), membrane
(M) and cytosol/nuclear (C) fractions were analyzed by Western blot analysis with
anti-GFP antibody. NS: non-speciﬁc bands.
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showed nuclear localization which was in good agreement with
the fact that in this case the N-terminal myristoylation site was
inactivated by the fusion tag (Fig. 3B).
We further examined the intracellular distribution of CCNY by
subcellular fractionation. Wild type CCNY (CCNY-GFP) was more
abundant in the membrane fraction. In contrast, the CCNY G2A
mutant (G2A-GFP) was enriched in the cytosolic/nuclear fraction
(Fig. 3C). The results of the fractionation experiment agree wellwith these localization patterns shown in Fig. 3B. These results
indicate that CCNY is also targeted to the membrane by N-myris-
toylation, in a similar manner to p35 and p39 [20].
3.4. CCNY recruits PFTK1 to the plasma membrane
CCNY is a PFTK1 interacting protein (Figs. 1 and 5). However,
the two interacting proteins seem to be located within different
subcellular compartments. Ectopic expressed PFTK1 mainly local-
ized in cytoplasm while ectopic expressed CCNY localized in the
plasma membrane (Figs. 3B and 4C). Overexpression of proteins
may cause them mislocalization, we decided to investigate
whether endogenous CCNY and PFTK1 are located in different sub-
cellular compartments. We were unable to detect the endogenous
CCNY and PFTK1 proteins by immunoﬂuorescence in any cell types
studied presumably because of limited sensitivity of the antibodies
available. Therefore, we used subcellular fractionation of mouse
testis that had high CCNY and PFTK1 mRNA levels to examine their
localization. The results showed that both CCNY and PFTK1 were
predominantly localized in the membrane and cytosol fractions
in mouse testis, with a small amount detected in the nuclear frac-
tion (Fig. 4B).
CCNY alone could bind to the membrane (Fig. 4C), while PFTK1
alone does not show a speciﬁc distribution in the membrane
(Fig. 4C). When PFTK1 co-expressed with CCNY-Myc, the two pro-
teins are co-localized in the membrane (Fig. 4D), indicating that
the CCNY determines the membrane localization of PFTK1.
We noticed that N-terminal HA tagged CCNY (HA-CCNY)
showed predominantly nuclear staining with some cytoplasmic
staining (Fig. 4C). There was reduced nuclear expression of HA-
CCNY compared with GFP-CCNY. Thus the remarkable nuclear
localization of GFP-CCNY might be an artifact caused by GFP tag
(Fig. 3B). When we co-expressed GFP-PFTK1 with HA-CCNY in
293T cells, HA-CCNY could not direct GFP-PFTK1 to the nucleus,
in contrast, the two proteins were co-localized in cytoplasm
(Fig. 4D). The results suggested that the CCNY might direct PFTK1
to the plasma membrane, once released from the membrane, CCNY
could still co-localize with PFTK1 in the cytoplasm.
3.5. Binding of CCNY to PFTK1 enhances the PFTK1 kinase activity
Interaction between the PFTK1 and CCNY was proved in the
yeast two-hybrid assay, and provided the ﬁrst evidence that CCNY
is a regulatory partner of the PFTK1. To examine the endogenous
association between CCNY and PFTK1, we used a rabbit polyclonal
anti-PFTK1 antibody to immunoprecipitate PFTK1 from mouse
brain. We could readily detect CCNY in the PFTK1 immunoprecip-
itates but could not detect any endogenous CCNY in the control
rabbit IgG precipitates, indicating that the two proteins indeed
interact each other in vivo (Fig. 5A). The result was consistent with
the yeast two-hybrid data. We further analyzed the interaction be-
tween PFTK1 and the membrane-associated form or cytoplasmic
form of CCNY by co-immunoprecipitation analysis. The co-IP
experiments showed that both CCNY-Myc (Fig. 5B) and HA-CCNY
(Fig. 5C) could speciﬁcally bind to PFTK1 but not to PFTK1 F176D
mutant, demonstrating that the CCNY interacts with PFTK1 inde-
pendently of its cytoplasmic or membrane-associated form.
We have showed that CCNY could recruit PFTK1 to the plasma
membrane and regulate the subcellular distribution of PFTK1.
The cellular localization of proteins is closely related to their func-
tions. Therefore, we tried to ﬁnd the different substrates of PFTK1–
CCNY complex corresponding to their subcellular localizations.
Firstly, we found that the membrane-associated CCNY was phos-
phorylated. The exogenously expressed CCNY-Myc showed a
hybridization band with anti-Phospho-Serine antibody (Fig. 5D),
but not with anti-Phospho-Threonine or anti-Phospho-Tyrosine
Fig. 4. Intracellular localization of CCNY–PFTK1 complex. (A) Characterization of a polyclonal rabbit antibody against full length CCNY. The 293T cells were transfected with
the plasmid of pEGFPC2-CCNY or pEGFPC2. Cell lysates were subjected to 8% SDS–PAGE and blotted with rabbit polyclonal anti-CCNY antibody or with anti-GFP antibody
(Santa Cruz) as a control. The anti-GFP antibody (Santa Cruz) recognized both the proteins, whereas the anti-CCNY antibody speciﬁcally recognized CCNY but not GFP. (B)
Subcellular localization of endogenous CCNY and PFTK1 in fractionated testis. The mouse testis extracts were fractionated into membrane (M), cytosolic (C) and nuclear (N)
fractions. The fractions were analyzed by Western blot. (C) Subcellular localization of exogenous CCNY and PFTK1 in 293T cells. 293T cells were transiently transfected with
pMycN3-CCNY (CCNY-Myc), pcDNA3-3HA-CCNY (HA-CCNY) and pEGFPC2-PFTK1 (GFP-PFTK1), respectively for indirect immunoﬂuorescence analysis. (D) Co-localization of
exogenous PFTK1 and CCNY in 293T cells. Bars represent 10 lm.
2176 M. Jiang et al. / FEBS Letters 583 (2009) 2171–2178antibody (data not shown), suggesting that the membrane-associ-
ated CCNY was phosphorylated at serine residue(s). The serine-
phosphorylation was only observed in membrane-associated
CCNY, but not in cytoplasmic CCNY (HA-CCNY) nor nuclear CCNY
(CCNY-G2A-Myc) (data not shown), suggesting that the CCNY
could be phosphorylated in membrane. PFTK1 might be required
for the phosphorylation of CCNY, since the phosphorylation was
enhanced by co-expression with PFTK1 (Fig. 5D). To demonstratethe phosphorylation of CCNY is catalyzed by PFTK1, the CCNY
was co-expressed with PFTK1 F176D mutant (CCNY binding site)
or PFTK1 K164R mutant (Predicted kinase ATP binding site). The
expression of PFTK1 F176D or K164R did not increase CCNY phos-
phorylation level (data not shown). The results suggest that PFTK1
is involved in regulation of CCNY phosphorylation in membrane,
although we cannot rule out the possibility that CCNY is also
phosphorylated by other protein kinases. To conﬁrm the
Fig. 5. CCNY interacts with PFTK1 in vivo and enhances its kinase activity. (A) Endogenous interaction between CCNY and PFTK1 in mouse brain. Lysates from mouse brain
were immunoprecipitated using rabbit polyclonal anti-PFTK1 or rabbit IgG as a control. The immunoprecipitates were blotted with anti-CCNY. (B) Co-immunoprecipitation of
CCNY-Myc and GFP-PFTK in 293T cells. (C) Co-immunoprecipitation of HA-CCNY and GFP-PFTK1 in 293T cells. (D) Enhanced phosphorylation of CCNY through its association
with PFTK1. The 293T cells transfected with indicated constructs were harvested. Equal amounts of cell lysates were subsequently blotted with anti-GFP, anti-Myc or anti-
phosphoserine antibody. Untransfected 293T cells were used as a control. (E) CCNY is phosphorylated at serine residue(s) in vivo. Lysates from the mouse brain were prepared
and immunoprecipitated by anti-CCNY antibody or IgG as a control. The immunoprecipitates were blotted with anti-CCNY antibody or anti-phosphoserine (anti-P-Ser). (F)
Kinase assay of PFTK1 from cytoplasm fraction. The 293T cells expressed with GFP-PFTK1 and HA-CCNY both or separately were harvested. One half of the
immunoprecipitants was used for blotting with anti-GFP or anti-HA (upper). The other half was used for kinase assay (lower).
M. Jiang et al. / FEBS Letters 583 (2009) 2171–2178 2177phosphorylation of CCNY in vivo, immunoprecipitates from mouse
brain by anti-CCNY antibody were blotted with anti-CCNY anti-
body or anti-phosphoserine. Hybridization band was observed
with both anti-CCNY and anti-phosphoserine antibodies (Fig. 5E),
consistent with the results from exogenously expressed CCNY-
Myc. Next, we examined whether the PFTK1 kinase activity is reg-
ulated by CCNY in the cytoplasm. Consistent with previous reports
[3], both the autophosphorylation of PFTK1 and phosphorylation ofRbC137 could be detected. These phosphorylations were both
slightly enhanced in the presence of HA-CCNY (Fig. 5F). Although
histone H1 and myelin basic protein have also been examined as
substrates, neither of them was found to be phosphorylated by
the CCNY–PFTK1 complex (data not shown). Taken together, we
suggest that the CCNY is a regulatory partner of the PFTK1, as bind-
ing of CCNY to the PFTK1 activates PFTK1, changes its cellular dis-
tribution and may also alter its substrate speciﬁcity.
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